On 23 October, members of the LETHE and Multi-MeMo Advisory Boards (AB) participated in a joint informative event focused on dementia medications. The online session was organised by Alzheimer Europe (AE) and provided an opportunity for AB members to deepen their understanding of current developments in this important area. We extend our thanks to Prof. Alina Solomon from the University of Eastern Finland, for her engaging presentation. She covered the latest therapies in development, including lecanemab and donanemab, two anti-amyloid therapies currently under regulatory review in Europe for early Alzheimer’s disease. The presentation was followed by an interactive Q&A session, allowing members to engage in a lively discussion about the topics raised.
AE Public Involvement Lead Ana Diaz, Public Involvement Officer Sarah Campill and Project Officer Cindy Birck, participated in the meeting. The LETHE project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement no 101017405. https://www.lethe-project.eu/
Multi-MeMo is an EU Joint Programme – Neurodegenerative Disease Research (JPND) project. The project is supported through the following funding organisations under the aegis of JPND – www.jpnd.eu: Finland, Research Council of Finland; Germany, Federal Ministry of Education and Research; Luxembourg, National Research Fund; Netherlands, The Netherlands Organisation for Health Research and Development; Slovakia, Ministry of Education, Science, Research and Sport of the Slovak Republic; Spain, National Institute of Health Carlos III.